Germany · Delayed Price · Currency is EUR Denali Therapeutics Statistics
Total Valuation
MUN:4DN has a market cap or net worth of EUR 2.30 billion. The enterprise value is 1.58 billion.
| Market Cap | 2.30B |
| Enterprise Value | 1.58B |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 146.66M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.46% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 4.78% |
| Owned by Institutions (%) | 96.02% |
| Float | 132.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.91 |
| P/TBV Ratio | 2.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.71 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.50 |
Financial Position
The company has a current ratio of 9.79, with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.79 |
| Quick Ratio | 9.43 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | -782.60 |
Financial Efficiency
Return on equity (ROE) is -44.44% and return on invested capital (ROIC) is -29.24%.
| Return on Equity (ROE) | -44.44% |
| Return on Assets (ROA) | -27.29% |
| Return on Invested Capital (ROIC) | -29.24% |
| Return on Capital Employed (ROCE) | -56.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -822,204 |
| Employee Count | 422 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MUN:4DN has paid 57,956 in taxes.
| Income Tax | 57,956 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -45.82% |
| 50-Day Moving Average | 17.20 |
| 200-Day Moving Average | 35.63 |
| Relative Strength Index (RSI) | 42.20 |
| Average Volume (20 Days) | 153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | -358.53M |
| Operating Income | -466.91M |
| Pretax Income | -425.02M |
| Net Income | -425.08M |
| EBITDA | -462.01M |
| EBIT | -466.91M |
| Earnings Per Share (EPS) | -2.48 |
Balance Sheet
The company has 722.92 million in cash and 37.91 million in debt, giving a net cash position of 706.07 million.
| Cash & Cash Equivalents | 722.92M |
| Total Debt | 37.91M |
| Net Cash | 706.07M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 789.40M |
| Book Value Per Share | 5.38 |
| Working Capital | 675.41M |
Cash Flow
In the last 12 months, operating cash flow was -339.03 million and capital expenditures -11.14 million, giving a free cash flow of -350.16 million.
| Operating Cash Flow | -339.03M |
| Capital Expenditures | -11.14M |
| Free Cash Flow | -350.16M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MUN:4DN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.46% |
| Shareholder Yield | -9.46% |
| Earnings Yield | -18.52% |
| FCF Yield | -15.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |